JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

Key facts

Sponsor

PPD Development, LP

Intervention

Cohort B: paridiprubart(drug)

Enrollment

200 target

Eligibility

18 years · All sexes

Timeline

2025 – 2028

Study locations (30)

• University of Alabama Hospital, Birmingham, Alabama, United States
• Community Regional Medical Center, Fresno, California, United States
• Long Beach Memorial Medical Center, Long Beach, California, United States
• University of California Irvine Medical Center, Orange, California, United States
• University of California Davis Medical Center - Pulmonary Medicine, Sacramento, California, United States
• Denver Health Hospital and Authority, Denver, Colorado, United States
• MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
• Nova Clinical Research, Bradenton, Florida, United States
• North Florida / South Georgia Veterans Health System, Gainesville, Florida, United States
• Sarasota Memorial Hospital, Sarasota, Florida, United States
• St. Luke's Boise Medical Center, Boise, Idaho, United States
• Northshore University Healthsystem Research Institute, Evanston, Illinois, United States
• OSF Saint Francis Medical Center-, Peoria, Illinois, United States
• Tufts Medical Center, Boston, Massachusetts, United States
• Lahey Hospital and Medical Center, Burlington, Massachusetts, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

Biomedical Advanced Research and Development Authority · InflaRx GmbH · Edesa Biotech Inc. · Genentech, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Infant acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07395076
  Study of the Immunological Pathophysiological Mechanisms Associated With Acute Respiratory Distress Syndrome
  Assistance Publique - Hôpitaux de Paris
• RECRUITINGNCT07344714
  Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting
  Mayo Clinic
• RECRUITINGPHASE4NCT07350018
  Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome
  Uludag University
• RECRUITINGNANCT07514481
  LISA vs Endotracheal Surfactant in Preterm Neonates: A Lung Ultrasound Distribution Study
  Hamad General Hospital
• RECRUITINGNANCT07248995
  Contribution of Transthoracic and Transcranial Ultrasonography to the Titration of PEEP in Patients With ARDS and ABI
  Theodoros Schizodimos
• RECRUITINGNCT07216053
  Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates
  Hackensack Meridian Health
• RECRUITINGNANCT03736707
  High-Frequency Oscillation Ventilation Versus Conventional Mechanical Ventilation in Very Preterm Infants With Perinatal Acute Respiratory Distress Syndrome: Multicenters Randomized Controlled, Superiority Trial
  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
• RECRUITINGPHASE3NCT06776783
  Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
  Aerogen Pharma Limited

See all trials for Infant acute respiratory distress syndrome →